The Effect of Salusin-β on Expression of Pro- and Anti-inflammatory Cytokines in Human Umbilical Vein Endothelial Cells (HUVECs)

Overview

Journal ARYA Atheroscler

Date 2018 Jun 27

PMID 29942332

Citations 9

Authors

Maryam Esfahani

Masoud Saidijam

Rezvan Najafi

Mohammad Taghi Goodarzi

Ahmad Movahedian

Affiliations

Soon will be listed here.

Abstract

Background: Atherosclerosis is one of the predominant causes of cardiovascular disease (CVD). Several studies indicated the significant pathophysiological role of salusin-β in atherosclerosis. Cytokines are involved in all stages of atherosclerosis. Therefore, we aimed to assess the effect of salusin-β on interleukin 6 (IL-6), interleukin 8 (IL-8), interleukin 18 (IL-18) (as inflammatory cytokines) and interleukin 1Ra (IL-1Ra) (as anti-inflammatory cytokines) levels in human umbilical vein endothelial cells (HUVECs).

Methods: The HUVECs were cultured in HUVEC completed medium and treated with different doses of salusin-β for 6 and 12 hours. For the investigation of nuclear factor ƙβ (NF-ƙβ) signaling pathway involvement, cells were treated in the presence or absence of Bay 11-7082 (as NF-ƙβ inhibitor). The mRNA expression and protein level of cytokines were measured by a real-time polymerase chain reaction (PCR) system and enzyme-linked immunosorbent assay (ELISA) method, respectively.

Results: Salusin-β increased mRNA expression and protein level of IL-6, IL-8 and IL-18. This protein decreased mRNA and protein level of IL-1Ra in HUVECs. NF-ƙβ signaling pathway was involved in the up-regulatory effect of salusin-β on mRNA expression of pro-inflammatory cytokines. The down-regulatory effect of salusin-β on IL-1Ra expression could not be influenced by Bay 11-7082 pre-treatment.

Conclusion: It seems that salusin-β may participate in a cascade pathway in vascular inflammation. Our findings suggested that salusin-β has potential use as a therapeutic target for atherosclerosis.

Citing Articles

The role of splicing events in the inflammatory response of atherosclerosis: molecular mechanisms and modulation.

Wang A, Wang C, Xuan B, Sun Y, Li B, Zhao Q Front Immunol. 2025; 15:1507420.

PMID: 39742258 PMC: 11685076. DOI: 10.3389/fimmu.2024.1507420.

Overexpression of salusin‑β downregulates adipoR1 expression to prevent fatty acid oxidation in HepG2 cells.

Xu A, Wang L, Luo M, Zhang H, Ning M, Pan J Mol Med Rep. 2023; 29(2).

PMID: 38063230 PMC: 10784734. DOI: 10.3892/mmr.2023.13141.

Knockdown of Salusin- Improves Cardiovascular Function in Myocardial Infarction-Induced Chronic Heart Failure Rats.

Xu Y, Pan Y, Wang X, Chen A, Tang X, Liu X Oxid Med Cell Longev. 2021; 2021:8896226.

PMID: 34422210 PMC: 8373485. DOI: 10.1155/2021/8896226.

Salusin-β Mediates High Glucose-Induced Inflammation and Apoptosis in Retinal Capillary Endothelial Cells via a ROS-Dependent Pathway in Diabetic Retinopathy.

Wang H, Zhang M, Zhou H, Cao L, Zhou J, Chen Q Diabetes Metab Syndr Obes. 2021; 14:2291-2308.

PMID: 34054302 PMC: 8153208. DOI: 10.2147/DMSO.S301157.

Improvement of Vascular Function by Knockdown of Salusin-β in Hypertensive Rats via Nitric Oxide and Reactive Oxygen Species Signaling Pathway.

Pan Y, Sun S, Wang X, Chen A, Fei X, Wang W Front Physiol. 2021; 12:622954.

PMID: 33897447 PMC: 8063058. DOI: 10.3389/fphys.2021.622954.

References

Munoz C, Pascual-Salcedo D, Castellanos M, Alfranca A, Aragones J, Vara A . Pyrrolidine dithiocarbamate inhibits the production of interleukin-6, interleukin-8, and granulocyte-macrophage colony-stimulating factor by human endothelial cells in response to inflammatory mediators: modulation of NF-kappa B and AP-1.... Blood. 1996; 88(9):3482-90. View

Bevilacqua M, Pober J, Majeau G, COTRAN R, Gimbrone Jr M . Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med. 1984; 160(2):618-23. PMC: 2187463. DOI: 10.1084/jem.160.2.618. View

Chandrasekar B, Colston J, de la Rosa S, Rao P, Freeman G . TNF-alpha and H2O2 induce IL-18 and IL-18R beta expression in cardiomyocytes via NF-kappa B activation. Biochem Biophys Res Commun. 2003; 303(4):1152-8. DOI: 10.1016/s0006-291x(03)00496-0. View

Rezaee-Zavareh M, Tohidi M, Sabouri A, Ramezani-Binabaj M, Sadeghi-Ghahrodi M, Einollahi B . Infectious and coronary artery disease. ARYA Atheroscler. 2016; 12(1):41-9. PMC: 4834180. View

Suk K, Yeou Kim S, Kim H . Regulation of IL-18 production by IFN gamma and PGE2 in mouse microglial cells: involvement of NF-kB pathway in the regulatory processes. Immunol Lett. 2001; 77(2):79-85. DOI: 10.1016/s0165-2478(01)00209-7. View

Krishnaswamy G, Kelley J, Yerra L, Smith J, Chi D . Human endothelium as a source of multifunctional cytokines: molecular regulation and possible role in human disease. J Interferon Cytokine Res. 1999; 19(2):91-104. DOI: 10.1089/107999099314234. View

Apostolakis S, Vogiatzi K, Amanatidou V, Spandidos D . Interleukin 8 and cardiovascular disease. Cardiovasc Res. 2009; 84(3):353-60. DOI: 10.1093/cvr/cvp241. View

Dewberry R, HOLDEN H, Crossman D, Francis S . Interleukin-1 receptor antagonist expression in human endothelial cells and atherosclerosis. Arterioscler Thromb Vasc Biol. 2000; 20(11):2394-400. DOI: 10.1161/01.atv.20.11.2394. View

Morel J, Park C, Woods J, Koch A . A novel role for interleukin-18 in adhesion molecule induction through NF kappa B and phosphatidylinositol (PI) 3-kinase-dependent signal transduction pathways. J Biol Chem. 2001; 276(40):37069-75. DOI: 10.1074/jbc.M103574200. View

10.

Tedgui A, Mallat Z . Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev. 2006; 86(2):515-81. DOI: 10.1152/physrev.00024.2005. View

11.

Kleemann R, Zadelaar S, Kooistra T . Cytokines and atherosclerosis: a comprehensive review of studies in mice. Cardiovasc Res. 2008; 79(3):360-76. PMC: 2492729. DOI: 10.1093/cvr/cvn120. View

12.

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

13.

McLaren J, Michael D, Ashlin T, Ramji D . Cytokines, macrophage lipid metabolism and foam cells: implications for cardiovascular disease therapy. Prog Lipid Res. 2011; 50(4):331-47. DOI: 10.1016/j.plipres.2011.04.002. View

14.

Aksu K, Donmez A, Keser G . Inflammation-induced thrombosis: mechanisms, disease associations and management. Curr Pharm Des. 2012; 18(11):1478-93. DOI: 10.2174/138161212799504731. View

15.

Cavusoglu E, Marmur J, Yanamadala S, Chopra V, Hegde S, Nazli A . Elevated baseline plasma IL-8 levels are an independent predictor of long-term all-cause mortality in patients with acute coronary syndrome. Atherosclerosis. 2015; 242(2):589-94. DOI: 10.1016/j.atherosclerosis.2015.08.022. View

16.

Kerr R, Stirling D, Ludlam C . Interleukin 6 and haemostasis. Br J Haematol. 2001; 115(1):3-12. DOI: 10.1046/j.1365-2141.2001.03061.x. View

17.

Schieffer B, Schieffer E, Hilfiker-Kleiner D, Hilfiker A, Kovanen P, Kaartinen M . Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability. Circulation. 2000; 101(12):1372-8. DOI: 10.1161/01.cir.101.12.1372. View

18.

Li A, Dubey S, Varney M, Dave B, Singh R . IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol. 2003; 170(6):3369-76. DOI: 10.4049/jimmunol.170.6.3369. View

19.

Koya T, Miyazaki T, Watanabe T, Shichiri M, Atsumi T, Kim-Kaneyama J . Salusin-β accelerates inflammatory responses in vascular endothelial cells via NF-κB signaling in LDL receptor-deficient mice in vivo and HUVECs in vitro. Am J Physiol Heart Circ Physiol. 2012; 303(1):H96-105. DOI: 10.1152/ajpheart.00009.2012. View

20.

Merhi-Soussi F, Kwak B, Magne D, Chadjichristos C, Berti M, Pelli G . Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice. Cardiovasc Res. 2005; 66(3):583-93. DOI: 10.1016/j.cardiores.2005.01.008. View